Peer-influenced content. Sources you trust. No registration required. This is HCN.
Alzheimer’s News Today
Blarcamesine (Anavex 2-73), an investigational once-daily oral autophagy enhancer, showed sustained cognitive, functional, and brain volume benefits through nearly 3 years in a Phase 2b/3 trial and open-label extension presented at AD/PD 2026.
Geriatrics May 14th 2026
Medical Xpress
A retrospective ADNI cohort analysis found that omega-3 supplement users showed faster cognitive decline over 5 years than matched non-users, with FDG-PET evidence of reduced brain glucose metabolism.
Family Medicine/General Practice May 14th 2026
Neurology Advisor
Multiple Alzheimer disease biomarkers showed accelerated age-related changes near age 70 in a Mayo Clinic Study of Aging cohort, identifying potential screening and monitoring windows.
MDLinx
In a small neuroimaging substudy of children exposed to prenatal stress during Superstorm Sandy, stronger early adaptive skills were associated with limbic activation patterns resembling unexposed peers.
Neurology May 7th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS